Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Up 26.4% in July

Bioxytran, Inc. (OTCMKTS:BIXT) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 11,500 shares, a growth of 26.4% from the June 30th total of 9,100 shares. Based on an average trading volume of 181,200 shares, the short-interest ratio is presently 0.1 days.

Bioxytran Stock Down 4.2 %

OTCMKTS:BIXT traded down $0.01 during trading hours on Tuesday, hitting $0.12. 8,883 shares of the company were exchanged, compared to its average volume of 87,563. The company has a fifty day simple moving average of $0.11 and a 200 day simple moving average of $0.12. Bioxytran has a one year low of $0.07 and a one year high of $0.35.

Bioxytran Company Profile

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.